Ticker | Company | Zen Score | Valuation Score | Financials Score | Forecast Score | Performance Score | Dividends Score |
---|---|---|---|---|---|---|---|
PCRX | PACIRA BIOSCIENCES INC | 67 | 100 | 71 | 56 | 40 | – |
CORT | CORCEPT THERAPEUTICS INC | 67 | 71 | 71 | 56 | 70 | – |
INCY | INCYTE CORP | 64 | 86 | 86 | 56 | 30 | – |
NBIX | NEUROCRINE BIOSCIENCES INC | 64 | 43 | 86 | 67 | 60 | – |
MOH | MOLINA HEALTHCARE INC | 64 | 43 | 86 | 56 | 70 | – |
Upgrade to Premium to View MoreUse Zen Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail. Already have a premium account? Sign In |
Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
680 | +0.73% | -1.37% | +1.10% | -19.83% | 8.12x | 6.05x | +18.58% | +3.64% | -28.41% | +80.60% | Strong Buy | ||
66 | +1.86% | +7.60% | +9.41% | +9.90% | 37.94x | 4.42x | -13.06% | +6.40% | +11.34% | +6.06% | Buy | ||
18 | +0.52% | +0.76% | +5.98% | +15.71% | 31.30x | 6.36x | +33.50% | +8.08% | +14.20% | +11.91% | Buy | ||
88 | +0.55% | -0.13% | +6.18% | -13.12% | -2.86x | 2.16x | +11.73% | +3.90% | +6.88% | +33.30% | Strong Buy | ||
12 | -0.08% | +1.59% | +5.67% | +3.70% | 25.10x | 3.02x | +15.15% | +4.73% | +11.75% | +13.30% | Buy | ||
56 | -0.07% | -2.90% | -2.42% | -21.75% | 11.78x | 3.33x | +6.87% | +2.32% | +5.85% | +32.10% | Buy | ||
47 | +0.76% | +1.55% | +3.12% | +11.96% | 40.51x | 4.58x | -92.16% | +6.58% | +13.66% | +14.04% | Buy | ||
155 | +1.29% | -1.69% | +0.61% | -14.13% | 29.59x | 3.94x | +7.14% | +5.15% | +8.26% | +21.26% | Buy | ||
10 | -0.40% | +0.03% | +0.22% | +26.25% | 26.34x | 105.24x | -10.32% | +3.42% | +19.53% | +10.81% | Buy | ||
52 | +1.88% | +1.85% | +4.72% | -6.86% | 59.11x | 3.56x | +11.29% | +7.71% | +10.06% | +18.68% | Buy |